A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage

Genes and Development

Volumn 10, Issue 8, 1996, Pages 934-947

  Linke, Steven P ^a,b   Clarkin, Kristie C ^a   Di Leonardo, Aldo ^a,c   Tsou, Amy ^a   Wahl, Geoffrey M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

antimetabolites; cell cycle control; normal human diploid fibroblasts; p21(WAF1 CIP1 SDI1); p53; pRb

Indexed keywords

PROTEIN P53; RIBONUCLEOTIDE;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CHROMOSOME ANALYSIS; DNA DAMAGE; DNA DETERMINATION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IRRADIATION; PRIORITY JOURNAL;

EID: 0029964158     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.8.934     Document Type: Article

References (54)

1. Almasan, A., S. Linke, T. Paulson, L.-C. Huang, and G. Wahl. 1995a. Genetic instability as a consequence of inappropriate entry and progression through S-phase. Cancer Metastasis Rev. 14: 59-73.
2. Almasan, A., Y. Yin, R.E. Kelly, E.Y. Lee, A. Bradley, and G.M. Wahl. 1995b- pRb deficiency leads to inappropriate entry into S phase, activation of E2F responsive genes and apoptosis. Proc. Natl. Acad. Sci. 92: 5436-5440.
3. Ausubel, P.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1994. Current protocols in molecular biology, Vol. 2, p. 10.2. Wiley/Greene, New York, NY.
4. Bertoni, L., C. Attolini, L. Tessera, E. Mucciolo, and E. Giulotto. 1994. Telomeric and nontelomeric (TTAGGG)n sequences in gene amplification and chromosome stability. Genomics 24: 53-62.
5. Bodner, S.M., J.D. Minna, S.M. Jensen, D. D'Amico, D. Carbone, T. Mitsudomi, J. Fedorko, D.L. Buchhagen, M.M. Nau, A.F. Gazdar et al. 1992. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7: 743-749.
6. Cadman, E. and C. Benz. 1980 Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin. Biochim. Biophys Acta 609: 372-382
7. Cadman, E.C., D.E. Dix, and R.E. Handschumacher. 1978. Clinical, biological, and biochemical effect of pyrazofurin. Cancer Res. 38: 682-688.
8. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
9. Cohen, M.B. and W. Sadee. 1983. Contributions of the depletions of guanine and adenine nucleotides to the toxicity of purine starvation in the mouse T lymphoma cell line. Cancer Res. 43: 1587-1591.
10. Collins, K.D. and G.R. Stark. 1971. Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. J. Biol Chem. 246: 6599-6605.
11. Cooney, D.A., H N. Jayaram, G. Gebeyehu, C.R. Betts, J.A. Kelley, V.E. Marquez, and D.G. Johns. 1982. The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. Biochem. Pharmacol. 31: 2133-2136.
12. Dbaibo, G.S., M.Y. Pushkareva, S. Jayadev, J.K. Schwarz, J.M. Horowitz, L.M. Obeid, and Y.A. Hannun. 1995 Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. 92: 1347-1351.
13. 1 checkpoint control. Cell 82: 675-684.
14. Di Leonardo, A., P. Cavolina, and A. Maddalena. 1993a. DNA topoisomerase II inhibition and gene amplification in V79/ B7 cells. Mutat. Res. 301: 177-182.
15. Di Leonardo, A., S.P. Linke, Y. Yin, and G.M. Wahl. 1993b. Cell cycle regulation of gene amplification. Cold Spring Harbor Symp. Quant. Biol 58: 655-667.
16. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev. 8: 2540-2551.
17. 1 arrest. Cell 76: 1013-1023.
18. 1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
19. Farnham, P.J., J.E. Slansky, and R. Kollmar. 1993. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta 1155: 125-131.
20. Fontoura, B.M., E. A. Sorokina, E. David, and R.B. Carroll. 1992. p53 is covalently linked to 5.8S rRNA. Mol. Cell. Biol. 12:5145-5151.
21. Gale, G.R. and G.B. Schmidt. 1968. Mode of action of alanosine. Biochem. Pharmacol. 17:363-368.
22. Halbert, C.L., G.W. Demers, and D.A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66: 2125-2134.
23. 1 cyclin-dependent kinases. Cell 75: 805-816.
24. Henderson, J.F. and A.R.P. Patterson. 1973. Nucleotide metabolism: An introduction, p. 48. Academic Press, New York, NY.
25. Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253: 49-53.
26. Huang, L.-Q, K.C. Clarkin, and G.M. Wahl. 1996. Sensitivity and selectivity of the p53-mediated DNA damage sensor. Proc. Natl. Acad. Sci. (in press)
27. Hupp, T.R., A. Sparks, and D.P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237-245.
28. Ishizaka, Y., M.V. Chernov, C.M. Burns, and G.R. Stark. 1995. p53-dependent growth arrest of REF52 cells containing newly amplified DNA Proc. Natl. Acad. Sci. 92: 3224-3228.
29. Jayadev, S., B. Liu, A.E. Bielawska, I.Y. Lee, F. Nazaire, M. Pushkareva, L.M. Obeid, and Y.A. Hannun. 1995. Role for ceramide in cell cycle arrest. J. Biol. Chem. 270: 2047-2052.
30. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
31. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597
32. Kuerbitz, S J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
33. Kuo, M.T., R.C. Vyas, L.X. Jiang, and W.N. Hittelman. 1994. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol. Cell Biol. 14: 5202-5211.
34. Li, W., J. Fan, D. Hochhauser, D. Banerjee, Z. Zielinski, A. Almasan, Y. Yin, R. Kelly, G.M. Wahl, and I.R. Bertino. 1995. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc. Natl. Acad. Sci. 92: 10436-10440.
35. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T.D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935.
36. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993a. p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74: 957-967.
37. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
38. Ma, C., S. Martin, B. Trask, and J.L. Hamlin. 1993. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes & Dev. 7: 605-620.
39. Marechal, V., B. Elenbaas, J. Piette, J.C. Nicolas, and A.J. Levine. 1994. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14: 7414-7420.
40. Moran, R.G., M. Mulkins, and C. Heidelberger. 1979. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. Proc. Natl. Acad. Sci. 76: 5924-5928.
41. Moyer, J.D., P.A. Smith, E.J Levy, and R.E. Handschumacher. 1982. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells. Cancer Res. 42: 4525-4531.
42. Moyer, J.D., N.M Malinowski, S.P. Treanor, and V.E. Marquez. 1986. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice Cancer Res. 46: 3325-3329.
43. Nasmyth, K. 1993. Control of the yeast cell cycle by the Cdc28 protein kinase. Curr. Opin. Cell Biol. 5: 166-179.
44. Nelson, W.G and M.B. Kastan. 1994. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14: 1815-1823.
45. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
46. Pogolotti, A.J. and D.V. Santi. 1982. High-pressure liquid chromatography-ultraviolet analysis of intracellular nucleotides. Anal. Biochem. 126: 335-345.
47. Santi, D.V., C S. McHenry, and H. Sommer. 1974. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate, Biochemistry 13: 471-481.
48. Savage, J.R. 1976. Classification and relationships of induced chromosomal structual changes. J. Med. Genet. 13: 103-122.
49. Scheffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
50. Sherley, J.L. 1991. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J. Biol. Chem. 266: 24815-24828.
51. Skoog, L. and B. Nordenskjold. 1971. Effects of hydroxyurea and 1-beta-D-arabinofuranosyl-cytosine on deoxyribonucleotide pools in mouse embryo cells. Eur. J. Biochem. 19: 81-89.
52. Windle, B., B.W. Draper, Y.X. Yin, S. O'Gorman, and G.M. Wahl. 1991. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes & Dev. 5: 160-174.
53. Xiong, Y., G.J. Hannon, H. Zhang, D Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
54. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.